
Ardent Health Stock Falls 19% on Filing for Offering by Selling Stockholders
Selling stockholders filed to offer 8 million shares in a prospectus supplement made the evening before the session.
Ardent Health, Inc. · NYSE · Services-General Medical & Surgical Hospitals, NEC

Selling stockholders filed to offer 8 million shares in a prospectus supplement made the evening before the session.
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Other events · Financial statements and exhibits
AI summary, unreviewedArdent Health discloses 8.0 million-share secondary offering by selling stockholders at $14.50, with company repurchasing 1.5 million shares for $13.7025 million...
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedArdent Health to acquire Boone Health for $47 million in cash, adding a 392-bed Missouri hospital system
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedArdent Health Q3 2026 GAAP EPS of $0.31 beats $0.24 consensus on $1.625 billion revenue; adjusted EBITDA guidance midpoint raised 1.5%, EPS guidance midpoint below consensus
Departure/appointment of directors or officers
AI summary, unreviewedArdent Health recharacterizes former CEO Martin Bonick's exit as a termination for Cause, cancels about $4.5 million severance and unvested PRSUs